1st Recommendations of Ovarian Cancer held in Paris the 30th of march 2012, continues…
AVASTIN AND TARGETED THERAPIES
J. Alexandre, F. Joly, C. Lhommé, F. Selle, E. Pujade – Lauraine, H. Curé
Continuing the discussion : debatreco@arcagy.org
WHAT KIND OF FOLLOW-UP?
Anne-Claire Hardy Bessard (St Brieuc), Patricia Pautier (Villejuif),
Dominique Berton‐Rigaud (Nantes),
Nadine Dohollou (Bordeaux)
Continuing the discussion : debatreco@arcagy.org
OVARIAN CANCER IN ELDERLY WOMEN
Claire FALANDRY, Michel FABBRO, Olivier GUERIN, Jean-Emmanuel KURTZ, Anne LESOIN
Continuing the discussion : debatreco@arcagy.org
SURGICAL MANAGEMENT & NEOADJUVANT CHEMOTHERAPY STAGE III-IV OVARIAN CANCER
JM. Classe, R. Rouzier, O.Glehen, P.Meeus, L.Gladieff, JM. Bereder, F Lécuru
Continuing the discussion : debatreco@arcagy.org
CHEMOTHERAPY AFTER FIRST LINE TREATMENT
Paul Cottu, Anne Floquet, Jean-Paul Guastalla, Alain Lortholary, Béatrice Weber
Continuing the discussion : debatreco@arcagy.org
Mise à jour 05/02/2016
